China National Medicines Corp Ltd
Research China National Medicines Corp Ltd (600511.SS) on Bullrun: market cap CNY 20.50B, P/E 10.6, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker600511.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyCNY
- Market capCNY 20.50B
- P/E10.6
- Dividend yield3.0%
- Financial periodQ2 2026
- RevenueCNY 13.17B
- Net incomeCNY 405.51M
- Free cash flowCNY 935.76M
- Gross margin5.9%
Valuation Snapshot
latest market cap is CNY 20.50B; P/E is 10.6; dividend yield is 3.0%.
Peer valuation comparison
Latest P/E is 10.61x versus a Healthcare sector median of 21.69x (51.1% below).
Latest dividend yield is 2.97% versus a Healthcare sector median of 2.41% (23.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 20.50B | 10.6 | 2.9% | 0.8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.8 CNY, yield 3.0%.
About China National Medicines Corp Ltd
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China National Medicines Corp Ltd's market cap?
China National Medicines Corp Ltd's market capitalization is CNY 20.50B.
What is China National Medicines Corp Ltd's P/E ratio?
China National Medicines Corp Ltd's price-to-earnings (P/E) ratio is 10.6.
Does China National Medicines Corp Ltd pay a dividend?
China National Medicines Corp Ltd has a dividend yield of 3.0%.
What does China National Medicines Corp Ltd do?
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co. Ltd.